Effect of halofenate on serum lipids.
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D006016:Glycolates / Q000627:therapeutic use*; D006218:Halofenate / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D010919:Placebos; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D000924:Anticholesteremic Agents; D006016:Glycolates; D000960:Hypolipidemic Agents; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D006218:Halofenate